Leadership

Stephen Bloch, MD

Co-Founder and CEO

Alessandra Di Bacco

Venture Partner, Takeda Oncology

Denis Patrick

Vice President Emerging Science & Innovation, Managing Partner Pfizer Ventures, Head of Partnering Innovation

Ian Taylor, PhD

Chief Scientific Officer, Arvinas

Daguang Wang, PhD

Managing Director, Yonjin Venture, Board Observer

Derek Yoon

President and CEO, Solasta Ventures

Richard Flavell, PhD

Yale – Sterling Professor, Chairman Emeritus of Immunobiology, Howard Hughes Medical Institute Investigator

Susan Kaech, PhD

Salk Institute* – Director NOMIS Center for Immunobiology and Microbial Pathogenesis, NOMIS Chair

*Participation by Dr. Kaech as a member of the Scientific Advisory Board does not constitute or imply endorsement by the Salk Institute for Biological Studies

Nils Lonberg, PhD

Executive in Residence – Canaan Partners

Former SVP Biologics Discovery, Oncology Discovery – Bristol-Myers Squibb Partnered w/ Jim Allison on CTLA-4 drug development

Mario Sznol, MD

Co-Director, Yale Cancer Immunology; Skin Cancer institute

Leader of the Melanoma/Renal Cancer Translational Team, Former president Society of Immunotherapy in Cancer (SITC)

Stephen Bloch, MD

Co-Founder and CEO

Charles Fuchs MD, MPH

Senior Vice President, Global Head Oncology and Hematology Drug Development – Genentech Roche, Former Physician-in-Chief Yale-Smilow Cancer Center

Sidi Chen, PhD

Associate Professor, Group Leader, Department of Genetics & Systems Biology Institute, Yale Cancer Systems Biology Center

Yale University